A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1986
10/29/1986	EP0199301A1 Recombinant acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS
10/29/1986	EP0199085A2 Jomol, its derivatives, process for the preparation of these substances, their use and their production
10/29/1986	EP0199033A2 Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use
10/29/1986	EP0199018A2 Expression in e.coli of hybrid polypeptides containing the growth hormone releasing factor sequence
10/29/1986	EP0198921A1 Biologically-active xanthine derivatives
10/29/1986	EP0198866A1 Monoclonal antibodies and their use
10/29/1986	CN86103330A Process for the preparation of novel glycopeptide derivatives
10/29/1986	CN86102977A Production of protein
10/29/1986	CN86101878A Stable gamma interferon formulation
10/28/1986	USRE32271 Isolation of plasminogen activators useful as therapeutic and diagnostic agents
10/28/1986	US4620012 Spirocyclic aminoacid derivatives, processes for their preparation, agents containing them and their use and new spirocyclic aminoacids as intermediates and processes for their preparation
10/28/1986	US4619989 Bone morphogenetic protein composition
10/28/1986	US4619916 Tripeptide compounds containing pyroglutamic acid and tryptophan, process for their production and therapeutic applications
10/28/1986	US4619915 Antiinfection agents
10/28/1986	US4619914 Peptides which inhibit gonadotropin secretion-contraceptives
10/28/1986	US4619913 Treatments employing drug-containing matrices for introduction into cellular lesion areas
10/28/1986	CA1213231A1 Fibrinolytic enzymes, and methods for their production and pharmaceutical compositions containing them
10/28/1986	CA1213219A1 Pharmaceutical composition for the treatment of diabetes
10/28/1986	CA1213216A1 Purification method of human interferon
10/28/1986	CA1213215A1 Stabilization of influenza virus vaccine
10/28/1986	CA1213214A1 Preparation of highly purified human antihemophilic factor
10/28/1986	CA1213213A1 Protein (pp.sub.1.sub.3), a process for enriching and isolating it and its use
10/28/1986	CA1213212A1 Protein (pp in17 xx), a process for concentrating and isolating it and its use
10/23/1986	WO1986006101A1 Novel procoagulant proteins
10/23/1986	WO1986006100A1 Human anti-inflammatory phospholipase inhibitor protein
10/23/1986	WO1986006096A1 Von willebrand factor
10/23/1986	WO1986006080A1 gamma-INTERFERON COMPOSITION
10/23/1986	WO1986006079A1 Purified protein having angiogenic activity and methods of preparation
10/23/1986	WO1986006076A1 Recombinant inhibin
10/23/1986	WO1986005977A1 Steroidal liposomes
10/22/1986	EP0198745A1 Method for the microbiological synthesis of human serum albumin
10/22/1986	EP0198388A2 Enterally effective biologically active peptide or protein composition, method for the production thereof, and a pharmaceutical composition containing same
10/22/1986	EP0198321A1 Medicament containing a plasminogen activator
10/22/1986	EP0198271A2 Peptides
10/22/1986	EP0198014A1 Vectors containing a gene for a protein having erythroid-potentiating activity and recombinant dna methods for producing said protein
10/22/1986	EP0198002A1 Monoclonal antibodies and their use
10/22/1986	EP0198001A1 Monoclonal antibodies and their use
10/22/1986	EP0197974A1 Acino-foetal differentiation proteins associated to the pancreas cancer, antiserum and monoclonal antibodies to said proteins, preparation methods
10/21/1986	US4618708 Enkephalinase inhibitor, analgesics, antidepressant, antidiarrhea, or hypotensive agent
10/21/1986	US4618600 Auriculin or analogs
10/21/1986	US4618599 Water solubility
10/21/1986	US4618598 Method of regulating hormone function or release
10/21/1986	US4618585 Hybridoma cell lines producing monoclonal antibodies directed against cervical cancer cells
10/21/1986	US4618577 Human-human hybridoma, CLNH5
10/21/1986	US4618495 Preparation for reducing cancer symptoms without treating cancer
10/21/1986	US4618492 Crosslinking agents that permit controlled release of amino-group-containing substances under mildly acidic conditions
10/21/1986	CA1212917A1 Process for preparing urokinase complex
10/21/1986	CA1212915A1 Process for the preparation of hybrid human leukocyte interferons
10/21/1986	CA1212902A1 Amino acid solutions for parenteral nutrition and methods of formulation and use
10/15/1986	EP0197901A1 Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations
10/15/1986	EP0197898A1 A formulation based on gelatin and glycine for treating the dryness of the skin
10/15/1986	EP0197798A2 Peptides
10/15/1986	EP0197794A2 Preparation of peptides with C-terminal proline amide
10/15/1986	EP0197718A2 New medicaments for topical use
10/15/1986	EP0197592A1 Preparation of the human von Willebrand factor by recombinant DNA
10/15/1986	EP0197558A2 Process for production of somatostatin
10/15/1986	EP0197554A2 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
10/15/1986	EP0197514A1 Pharmaceutical composition for use in increasing bone mass
10/15/1986	EP0197478A1 Diphosphonic-acid derivatives, process for preparing them and medicines containing these compounds
10/15/1986	EP0197149A1 Method of obtaining human leukocytic interferon
10/15/1986	EP0197111A1 Apparatus, substance and method for treatment for the immune system
10/15/1986	EP0197062A1 Anti-leishmania monoclonal antibodies, hybridomas secreting said antibodies, antigens of leishmania recognized by said antibodies, method for obtaining them and applications of said monoclonal antibodies and said antigens.
10/15/1986	EP0197059A1 Pharmacologically active peptide
10/14/1986	US4617379 High titer cytomegalovirus immune serum globulin
10/14/1986	US4617378 Purification of biologically active human immune interferon
10/14/1986	US4617377 Bactericides
10/14/1986	US4617291 Hypotensive agents
10/14/1986	US4617290 Bactericides
10/14/1986	US4617271 Embedding in hydrolyzed polyvinyl alcohol gel
10/14/1986	US4617149 Animal growth regulators
10/14/1986	CA1212627A2 Caries inhibition
10/09/1986	WO1986005810A1 Production of human somatomedin c
10/09/1986	WO1986005692A2 Treatment of adult respiratory distress syndrome
10/09/1986	WO1986005690A1 Fibronectine solution suitable for use with humans, and process for its manufacture
10/08/1986	EP0196921A2 Recombinant human renin
10/08/1986	EP0196920A2 Degraded species of tissue-type plasminogen activator, pharmaceutical composition and method of preparation
10/08/1986	EP0196841A1 N,N-dialkylguanidino dipeptides
10/08/1986	EP0196762A1 Recombinant ricin fragments, vectors and transformed hosts expressing the same, the modification of DNA sequences, and isolation of mRNA
10/08/1986	EP0196515A1 Photodynamic inactivation of virus in therapeutic protein compositions
10/08/1986	EP0116043B1 A method for dividing blood hemoglobin into heme and globin
10/08/1986	CN85109722A Process for preparing dynophine derivative
10/07/1986	US4616031 Perhydroindole-2-carboxylic acids as antihypertensives
10/07/1986	US4616030 Perhydroindole-2-carboxylic acids as antihypertensives
10/07/1986	US4616029 Perhydromdole-2-carboxylic acids as antihypertensives
10/07/1986	US4616012 Benzothiadizinyl and quinazolinyl derivatives
10/07/1986	US4615885 Pharmaceutical composition containing urokinase
10/07/1986	CA1212497A1 Crosslinked .beta.-alanine, and its various uses
10/07/1986	CA1212319A1 Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy
10/01/1986	EP0196226A2 Method for preparing a monoclonal antibody against plasminogen-activating factor
10/01/1986	EP0196203A2 Stable gamma interferon formulation
10/01/1986	EP0196197A2 Collagen implant material and method of preparing it
10/01/1986	EP0196185A2 Antiviral nucleosides
10/01/1986	EP0196146A2 Process for isolating and purifying alpha-interferons
09/1986
09/30/1986	US4614805 Bicyclic amino acids as intermediates in the preparation of tricyclic amino acids and processes for their preparation
09/30/1986	US4614795 High purity protein with carbohydrate side chains removed
09/30/1986	US4614793 Polypeptides
09/30/1986	US4614731 Peptide having immunopotentiating activity similar to thymosin alpha1
09/30/1986	US4614730 Using phospholipids
09/30/1986	US4614720 Hybridomas
09/30/1986	US4614651 Interferon epsilon

1 ... 3098 3099 3100 3101 3102 3103 3104 3105 3106 3107 3108 3109 3110 3111 3112 3113 3114 3115 3116 3117 3118 ... 3163